MedPath

Adequate therapy against low-dose aspirin-induced ulcer: comparison of two acid-inhibitory drugs, rabeprazole and famotidine (Quality study)

Not Applicable
Conditions
gastric ulcer during usage of low dose aspirin (80-100 mg/day)
Registration Number
JPRN-UMIN000007639
Lead Sponsor
Osaka City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with allergy for rabeprazole and famotidine 2. Patients who have taken endoscopic banding 3. Patients who have taken digestive surgical procedure 4. Patients under treatment of atazanavir sulfate 5. Patients who have taken proton pomp inhibiter within 2 weeks before endoscopy 6. Patients who have taken NSAIDS or steroid 7. Patients who have malignant neoplasm or serious disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of endscopic finding 4 weeks and 8 weeks after initiating rabeprazole or famotidine
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath